ABSTRACT
The discovery of endogenous adult neurogenesis within the mammalian brain has unwrapped wide expectation about the potential use of this process for nervous system repair and regeneration. Neural stem cells residing in specific niches are able to proliferate and differentiate, giving rise to migrating neuroblasts, which in turn mature into functional neurons. These new neurons integrate into the existing circuits and contribute to the structural plasticity of certain brain areas. However, recent evidence suggests that the process could become more general under pathological conditions. Adult neurogenesis increases under acute and chronic brain diseases. Neuronal precursors are directed to the lesioned areas where they contribute to tissue repair. Given this intrinsic capability of the adult brain for tissue regeneration, researchers are focusing on strategies aimed at manipulating endogenous neurogenesis to optimize therapeutic benefit. These new approaches depend on a better understanding of the physiological role of stem cells in situ, and the elucidation of the molecular cues governing neurogenesis in normal and pathological situations. In this work, I review what is actually known about the physiology of well-described adult neural stem cell populations, and how several factors defining their niches could be used to manipulate and direct the neurogenic process towards amelioration of disease.
INTRODUCTION
Recent evidence has changed the way we think about the adult mammalian nervous system. Contrary to previous dogma (1), we now know that adult neurogenesis continues in two regions of the adult mammalian brain, the dentate gyrus of the hippocampal formation and the subventricular zone and its projection to the olfactory bulb. The study of these areas revealed the existence of an outstanding population of cells capable of self-renewal and differentiation into all three central nervous system (CNS) differentiated cell types: astrocytes, oligodendrocytes and neurons. The so-called adult neural stem cells are responsible for the generation of new neurons within the neurogenic zones, and hence they direct the structural plasticity of the adult CNS function (2) .
The discovery and study of adult neural stem cells has raised vast expectation for the therapeutic treatment of neurological diseases. Various degenerative nervous system diseases result from the loss of neurons and their connections, impairing normal neural circuits and drastically reducing the patient's quality of life. Thus, recent biomedical research efforts, on an international scale, have been dedicated to the study of neural stem cell function, with the ultimate goal of using them as therapeutic agents. On the other hand, basic neuroscientists are interested in adult neural stem cells to understand tissue homeostasis. They investigate the basic mechanisms by which these cells contribute to tissue plasticity, maintenance and repair. However, these two approaches to the study of adult neural stem cell function are not always compatible. While clinically oriented experiments tend to focus on the expansion of neural stem cells in culture for therapeutic use, basic neuroscientists focus on understanding the physiological role of neural stem cells in vivo, which is incompatible with culturing the cells, since it has been shown that stem cells can dramatically change their properties when cultured in vitro (3) . Hence, since the behavior of neural stem cells in a culture dish can differ greatly from their behavior in vivo, researchers should proceed cautiously when using the cells for therapeutic purposes if they have been expanded in vitro. To reconcile both developmental science and clinical goals, perhaps the best approach for utilizing neural stem cells will be to take advantage of their normal physiology in order to improve the outcome of the disease. If we come to an understanding of the regulation of stem cell function in vivo, we should be able to use this knowledge to improve a disease outcome, by manipulating the stem cell behavior within the affected tissue. This seems a particularly interesting issue considering the limited and slow progress being made in the use of exogenously cultured neural cells for the treatment of disease (4, 5) .
This review tries to put together the current knowledge on the physiological function of known adult neural stem cell populations, including the dentate gyrus stem cells, the subventricular zone stem cells, and the neural crest-derived stem cells residing within the adult enteric nervous system (6) . By reviewing the regulatory mechanisms governing neurogenesis from these adult stem cells in vivo, we might develop new ideas on how to use their physiology for our therapeutic benefit. The actual known role of these adult neural stem cells in the pathophysiology of disease and the implications of their manipulation on clinical prognosis will also be discussed.
NEURAL CREST-DERIVED ENTERIC STEM CELLS PERSIST INTO ADULTHOOD BUT LITTLE IS KNOWN ABOUT THEIR PHYSIOLOGICAL ROLE
The peripheral nervous system (PNS) is formed by a population of neural stem cells that delaminate from the neuroectoderm during the closure of the neural tube (7, 8) . The so-called neural crest-derived stem cells (NCSCs) migrate during embryonic development towards multiple target tissues where they differentiate into a great variety of cell types including melanocytes, neurons, glia, neurosecretory cells or even cartilage and bone cells in certain areas. NCSC self-renewal and differentiation capacities vary during their migration towards their target tissues, although it has been shown that postmigratory cells can retain in vivo multilineage differentiation capabilities (9) .
NCSCs that give rise to the enteric nervous system have been prospectively identified and isolated by flow cytometry from mid-gestation embryos (10) . These cells are able to both self-renew extensively in culture and differentiate in vitro into all three typical neural crest cell lineages: neurons, glial cells and myofibroblasts (10) . They are also able to undergo multilineage differentiation in vivo after transplantation into the neural crest migration stream of developing chicken embryos (6, 10) . These gut NCSCs persist into adulthood but change their basic self-renewal and differentiation properties in vitro, including the neuronal subtypes they give rise to (6) . However, neurogenesis has not been reported within the adult enteric nervous system of the gut, raising the question about whether the gut NCSCs are able to behave as multipotent stem cells within the adult enteric tissue in situ.
To prove that gut neural stem cells are intrinsically neurogenic, transplantation experiments with fetal gut cells were performed to compare them with a different subpopulation of NCSCs, those isolated from the developing sciatic nerve. These peripheral nerve NCSCs also give rise to neurons, glial cells and myofibroblasts in the culture dish (10) . However, they have been shown to only differentiate into Schwann cells and endoneurial fibroblasts within the developing nerve (11) . They seem to have no neurogenic activity once they migrate into the nerves. Transplantation experiments of both gut and sciatic nerve fetal cells into developing chick nerves determined that, unlike the sciatic nerve cells, the gut cells were indeed able to differentiate into neurons in this environment (10) . These data suggest that, rather than responding to a restrictive nerve environment, different types of NCSCs have cell-intrinsic differences in neurogenic potential. Furthermore, enteric NCSCs seem to retain their neurogenic potential in the adult (6) . The fact that no neurogenesis has been described in the adult enteric nervous system could simply indicate that no appropriate stimuli have been found for that to happen. Impairment in the normal migration of gut NCSCs along the developing intestines has been shown to cause Hirschprung disease (12), a gut motility syndrome caused by a failure to form enteric nervous system ganglia in the colon. This can lead to fatal distention of the gut (megacolon). Therapeutic treatment of this disease by the transplantation of the patient's own gut NCSCs will first require knowledge about the molecular cues that might induce these cells to undergo neurogenesis within the aganglionic segments.
Two other cell populations have been recently described as adult pluripotent NCSCs. These populations were isolated from heart tissue (13) and from the hair follicle (14) .
However, these cells have not been prospectively isolated, and their multipotentiality has only been tested in vitro. Hence, it is not clear whether they have a multipotent and therapeutically useful physiological role within their tissues in vivo.
THE CENTRAL NERVOUS SYSTEM CONTAINS TWO DISCRETE NEUROGENIC NICHES
It seems clear that most mature neurons cannot replicate themselves once they are terminally differentiated.
The complexity of both their dendritic trees and the polysynaptic axonal branching make it impossible for them to re-enter a cell cycle and divide. These facts led to the long-lasting previous dogma of no structural plasticity within the CNS. However, a couple of decades ago, two rather discrete areas of the brain were described where new neurons were generated. The important finding was that these young neurons did not result from the division of old ones, but rather were the product of differentiation from neural precursors. The so-called neural stem cells exist throughout life in the adult brain and are able to self-renew and give rise to new neurons, astrocytes and oligodendrocytes.
They were first described in the subventricular zone (15, 16) , and then in the dentate gyrus of the hippocampus (17, 18), the two adult brain areas where neurogenesis has been demonstrated. Although other neural cells from other regions of the brain are able to respond to growth factors and even differentiate into neurons and glia in vitro, it is not clear whether these cells show this multipotentiality and regenerative power in vivo, hence they might not behave as true neural stem cells within the brain parenchyma (19) (20) (21) (22) .
It is therefore critical to analyze the mechanisms governing the course of neurogenesis in those two adult brain regions, and learn more about the in situ behavior of neural stem cells, if we want to be able to control the process and direct the migration of the precursors to other injured areas.
Adult neurogenesis from hippocampal stem cells
The hippocampus is located in the temporal lobe of the brain, forms part of the limbic system, and seems to play an important role in learning and memory. The hippocampal formation consists of pyramidal neurons forming the CA regions, and an interior and curved structure called the Dentate Gyrus (DG), formed by a layer of granule cell neurons. The subgranular layer (SGL) of the DG contains a subpopulation of astrocytes able to give rise to migrating neuroblasts, which in turn differentiate into granular neurons (23, 24) .
This hippocampal neurogenesis was originally highlighted by the immunohistochemical detection of bromodeoxyuridine (BrdU), a synthetic thymidine analogue incorporated into DNA by S-phase cells. Proliferating BrdU positive cells and their neuronal derivatives have been observed in the DG of every mammal examined, including humans (25) .
The SGL progenitor astrocytes have radial processes going through the granule cell layer, and short tangential processes extending along the border of the granular layer. Understanding what makes the SGL special in supporting the proliferation and neuronal differentiation of multipotent neural progenitors is crucial to be able to control the process and take advantage of it for therapeutic purposes. Members of the epidermal (EGF) and fibroblast (FGF) growth factor families are primary mitogens used to propagate the SGL stem cells in vitro and are likely to perform similar functions in vivo (26) . Activation of the Wnt pathway due to the presence of Wnt3a has also been shown to control the self-renewal of SGL progenitors (27) . Special astrocytes and endothelial cells have been postulated as the source of all this paracrine signaling, which would define a unique neurogenic niche (26, 28) . Hippocampal astrocytes, for example, promote proliferation and neuronal fate specification of co-cultured adult neural progenitors (29) . In contrast, astrocytes from non-neurogenic regions do not promote neuronal differentiation (29) . It becomes clear that astrocytes in the adult CNS are not merely supporting cells as traditionally believed, but, just as neurons, have a broad diversity of subtypes and functions.
The vascular nature of the neural niche is an area of intense investigation. Hot spots of cell proliferation within the SGL are found to be in close proximity to capillaries (28) , suggesting an intimate relationship between neurogenesis and vasculogenesis. Endothelial cells, co-cultured with neural progenitors, can stimulate self-renewal, and enhance neuron production (30) . Furthermore, the addition of vascular endothelial growth factor (VEGF), a typical vasculogenic factor, to the hippocampus of adult rats, induced a two-fold increase in the number of BrdU+ young neurons within the DG (31) . Colocalization of the VEGF receptor with the immature neuronal marker doublecortin (Dcx) suggested a direct action of VEGF on neuronal progenitors (32) . It becomes clear that vascular cells and vasculogenesis can influence the course of neurogenesis, suggesting the interesting possibility of controlling the neurogenic process by introducing exogenous vascular-associated factors.
Extensive research is being devoted to elucidating the functional consequences of the incorporation of new granule cells to the DG. Recent evidence indicates that the new neurons are able to integrate into the preexisting neural circuits, contributing to the functional plasticity of the two processes controlled by the hippocampus -learning and memory (33, 34) . The functional importance of the neurogenic process in the hippocampus is highly signified by the intimate relationship described between the local circuit activity and the proliferation and differentiation of the progenitors. Simply by exposing rodents to physical exercise, there is an increase in cell proliferation and neurogenesis in the adult DG (35) . More complicated behavioral tests, such as associative learning tasks, also clearly increase the number of adult-generated neurons within the DG (36) . These data indicate that at least in certain circumstances there is a need for new neurons in the hippocampus to contribute to the functional plasticity of the circuit. Numerous researchers are working on this activity-neurogenesis coupling, which will likely lead to better control of the neurogenic process and possible therapeutic applications.
Although little is known about the involvement of the hippocampal circuitry on the activity-neurogenesis coupling process, recent evidence indicates that the SGL progenitors receive active direct neural inputs (37, 38) . Malenka and col. demonstrated that the proliferating precursors sense the excitation via calcium channels and NMDA receptors, which in turn will translate to inhibition of glial genes and activation of neuronal genes such as NeuroD (37) . A GABAergic innervation of the progenitor cells has also been described, which depolarizes them, initiating an intracellular calcium rise and the expression of genes involved in neuronal differentiation such as NeuroD (38) .
Thus, it appears that GABAergic inputs to hippocampal progenitors promote activity-dependent neurogenesis. Moreover, hippocampal ambient GABA has also been shown to regulate synapse formation and dendritic development of the newborn neurons that incorporate into the granule cell layer (39) . Taken together, these data shed light on the mechanism for activitydependent regulation of adult hippocampal neurogenesis, indicating that progenitors and newborn neurons are able to sense neuronal network activity through multiple intracellular signaling pathways.
The vascular origin of the paracrine signaling and the activity dependence of the hippocampal neural niche are all aspects that will improve our ability to generate therapeutic applications from this neurogenic process.
Molecular mechanisms governing subventricular zone neurogenesis
Along the lateral walls of the lateral ventricles lies the largest germinal zone of the adult mammalian brain, the subventricular zone (SVZ) (40) . New neurons are continuously born in the SVZ to migrate anteriorly into the olfactory bulb (OB) where they differentiate into local interneurons (41) (42) (43) . The SVZ neural niche contains, in addition to the ependymal cells lining the ventricle, special astrocytes that are able to self-renew and give rise to transit-amplifying progenitors, which in turn differentiate into migrating neuroblasts (44) . Hence, the adult SVZ constitutes an important reservoir of neural stem cells that can be grown in culture with growth factors, but that could also be potentially manipulated in vivo to ameliorate the outcome of disease. The regulatory mechanisms governing SVZ neurogenesis need to be elucidated in order to be able to control the process for therapeutic purposes.
A common characteristic of the adult SVZ neural niche biology is the persistence of molecular morphogens and signals typical from the embryonic development. These molecular cues, reminiscent from the embryo, seem to control both the self-renewal and differentiation of the neural progenitors in this area (45) . Bone morphogenetic proteins (BMPs), commonly studied in ontogeny, were found to inhibit adult SVZ neurogenesis by cellautonomously blocking the production of neurons and directing glial differentiation (46) .
Moreover, SVZ ependymal cells express noggin, a BMP antagonist, which was found to promote neurogenesis and inhibit glial differentiation (46) . Hence, noggin creates a neurogenic environment in the SVZ by blocking endogenous BMP signaling. Another example is the secreted factor Sonic hedgehog (Shh), which plays multiple roles in the formation of the CNS, including the regulation of the early ventral patterning in the neural tube (47) . Recently, it has been shown that both SVZ astrocytic stem cells and transitamplifying progenitors respond to Shh signaling. Moreover, Shh regulates the self-renewal of neurosphereforming stem cells, and modulates the proliferation of SVZ lineages by acting as a mitogen in cooperation with epidermal growth factor (EGF) (48) .
These data demonstrate a critical and conserved role of Shh signaling in the regulation of stem cell lineages within the adult mammalian SVZ. Thus, major developmental signaling pathways, including Shh and BMPs, are retained in adult germinal niches such as the SVZ, where they appear to regulate important aspects of proliferation and differentiation, hence controlling the course of neurogenesis.
Similar to the SGL, the SVZ germinal area is also intimately associated to vascular tissue, and vascular cells and factors also regulate the SVZ neurogenic process (reviewed in 45, 49) .
Intraventricular infusion of erythropoietin (Epo), a potent vasculogenic factor, promoted neurogenesis by increasing the number of newly generated migrating neuroblasts and new OB interneurons (50) . Infusion of anti-Epo antibodies had the opposite effect: a decrease in the number of newly generated cells migrating to the bulb (50) . These findings suggest that Epo is a paracrine factor capable of regulating the production of neuronal progenitors by forebrain stem cells. The search for endothelium-derived factors that could have potential effects on the self-renewal and differentiation of SVZ progenitors recently led to the discovery of pigment epithelium-derived factor (PEDF) as a regulator of SVZ neurogenesis. Intraventricular PEDF infusion activated the proliferation of slowly dividing astrocytic stem cells, whereas a blockade of endogenous PEDF decreased their cycling (51) . These data further indicate the close relationship between neurogenesis and vasculogenesis within the SVZ germinal niche, suggesting new approaches to control this neurogenic process in pathological situations.
Another factor that may regulate the SVZ neurogenic activity could be the actual need for new neurons in the olfactory bulb. Extensive research is being devoted to understanding the process of survival and integration of newly formed neurons in the OB (reviewed in 52), processes that could influence neurogenesis in the SVZ. Recent results show that the newly formed cells arriving to the OB become mature neurons, following a unique sequence of electrophysiological events leading to their functional integration (53) .
However, rodents exposed to tasks of odor discrimination learning increase the number of adult-born neurons in the OB, but through increased survival of the new cells rather than an augmentation of SVZ neurogenesis (54) . These data suggest that, unlike in the case of the SGL, the activitydependent regulation of neurogenesis might not be that relevant in the SVZ.
NEURAL STEM CELL BEHAVIOR IN RESPONSE TO INJURY AND DISEASE -POSSIBLE MANIPULATIONS
Pathological conditions can alter ongoing adult neurogenesis.
Following ischemia or brain trauma, proliferation is increased in the SGL and SVZ neurogenic areas (55, 56) . Furthermore, non-neurogenic regions, such as cortex and striatum, also respond to injury by allowing new neurons to invade and integrate into the lesioned area (57) (58) (59) . However, other pathological conditions may have negative effects on adult neurogenesis. For example, chronic inflammation, following cranial radiation therapy, impairs neurogenesis within the hippocampus, which induces a debilitating cognitive decline in affected patients (60) . The data suggest that inflammatory processes may contribute to neural stem cell dysfunction (61) . Thus, adult neural stem cells can respond to different types of injury either positively by proliferating and migrating to the affected areas, or negatively by becoming damaged and impairing neurogenesis.
However, even in the case of injury-induced proliferation and differentiation of progenitors, the effect of this stem cell activity might not be beneficial for the disease outcome. In a rat model of limbic epilepsy, prolonged seizures caused an increase in dentate granule cell neurogenesis. However, these developing newborn granule cells projected axons aberrantly to the CA regions and the dentate inner granule layer, giving rise to anomalous network reorganization and epileptogenesis (62) . In this case, it seems more plausible to look for drugs that would inhibit stem cell function, in order to prevent their deleterious effects. Another common situation is when the new cells migrate and differentiate into the affected area, but then die soon after, due to lack of trophic support. In an experimental stroke model immature neurons migrate from the SVZ to the damaged striatal area where they start to express markers for striatal neurons. Most of these new neurons die between two and five weeks after the stroke (57) . These studies suggest that the local environment, although providing cues for attracting immature neurons and inducing neuronal subtype differentiation, is not adequate for long-term survival of the new neurons. Intraventricular infusion of trophic factors such as EGF or FGF-2 seemed to improve survival of the new neurons that incorporated in the hippocampus after global ischemia (63) . These results denote complementary strategies to take advantage of injury-induced neurogenesis.
The study of depression as a treatable disorder has led to very significant research aimed at understanding the role of adult neural stem cells in the pathophysiology of this disease. It has been reported that stress paradigms conducting to depression, as well as some animal models of the disease, produce a decrease in hippocampal cell proliferation and neurogenesis. Conversely, treatment with different classes of antidepressant drugs increases cell proliferation and neurogenesis (64, 65) .
A current hypothesis is that prevention of the decrease in neurogenesis may be one way to improve the antidepressant treatments. It has been proposed that factors favoring vasculogenesis and neurogenesis in the hippocampus, such as brain-derived neurotrophic factor (BDNF), VEGF, or FGF, could be intermediaries in the effector mechanism of antidepressants (66).
Finally, even chronic degenerative neurological disorders significantly alter adult neurogenesis. Brains from both Huntington and Alzheimer patients show an increase in the expression of proliferation and immature neuronal markers within the SGL, suggesting an activation of the hippocampal progenitors (67, 68) . In the case of Parkinson patients, an impairment of progenitor proliferation is observed in both SGL and SVZ areas (69) , presumably as a consequence of dopaminergic denervation. Thus, emerging evidence suggests that adult neurogenesis may be an intrinsic compensatory response to repair the adult CNS, and hence, it might be possible to manipulate this process for optimal therapeutic benefit.
PERSPECTIVE
In the past few decades we have witnessed the decline of an old dogma and the dawn of a new and exciting field of adult neurogenesis. The actual focus of this newly formed field is to understand the regulatory mechanisms and functions of neurogenesis, elucidating the stimuli and molecular cues governing the production of new neurons, and understanding the functions of these neurons and their effects on the homeostasis of the brain. Studies are converging on the adult neural stem cells, a special population of cells residing in specific niches, whose properties of proliferation and differentiation allow them to be responsible for the production of the new neurons. Recently, several niche factors modulating stem cell behavior have been characterized, as well as other molecules regulating the survival of the new neurons. It has also been shown that neurogenesis increases in the damaged brain, not only after stroke or traumatic injury, but also under various chronic neurodegenerative pathologies.
Remarkably, progenitors from the subventricular zone are incorporated to the damaged areas, where they apparently replace some of the sick neurons. Hence, the nervous system seems to have the potential capacity to repair itself. As a consequence, researchers are trying to develop strategies aimed at reinforcing neurogenesis within the diseased areas. Once we have observed evidences about the intrinsic capabilities of the adult brain for tissue repair, recent works focus on enhancing proper cell replacement by using molecular cues known to regulate the endogenous activity of the neural progenitors. Therefore, accumulating evidences allow us to be optimistic about a potential use of endogenous neurogenesis for nervous system repair and regeneration.
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